A Phase 2a Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1265744 Monotherapy Versus Placebo in HIV-1 Infected Adults (ITZ112929).
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2017
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors GlaxoSmithKline; ViiV Healthcare
- 15 Jun 2017 Last checked against ClinicalTrials.gov record.
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2013 Results published in HIV Clinical Trials.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History